Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation - The Lancet Diabetes & Endocrinology

life expectancy: Type 2 diabetes diagnosis at 30 may cut life expectancy by 14 years: Lancet study - The Economic Times

Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts

Type 1 diabetes—early life origins and changing epidemiology - The Lancet Diabetes & Endocrinology

Youth-onset type 2 diabetes mellitus: an urgent challenge

Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 - The Lancet Diabetes & Endocrinology

Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study - The Lancet Regional Health – Europe

Type 2 diabetes diagnosis at age 30 can reduce life expectancy by up to 14 years, warn experts

Diabetes free life expectancy and years of life lost associated with type 2 diabetes: projected trends in Germany between 2015 and 2040, Population Health Metrics

Type 2 diabetes diagnosis at age 30 can reduce life expectancy by up to 14 years

Estimating life expectancy based on the age of type 2 diabetes diagnosis

Many years of life lost to young-onset type 2 diabetes - The Lancet Diabetes & Endocrinology

Type 2 diabetes diagnosis at age 30 can reduce life expectancy by up to 14 years, warn experts

Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study - The Lancet Diabetes & Endocrinology

Type 2 Diabetes Diagnosis May Reduce Life Expectancy by up to 14 Years

Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Diabetes & Endocrinology